Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ji Zeng
Safety, Immunogenicity, and Lot-To-Lot Consistency of Live Attenuated Varicella Vaccine in 1-3 Years Old Children: A Double-Blind, Randomized Phase III Trial
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
Safety and Immunogenicity of a Live Attenuated Mumps Vaccine
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus Naive Children
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
The Safety and Immunogenicity of Two Novel Live Attenuated Monovalent (Serotype 2) Oral Poliovirus Vaccines in Healthy Adults: A Double-Blind, Single-Centre Phase 1 Study
The Lancet
Medicine
Efficacy of a Russian-Backbone Live Attenuated Influenza Vaccine Among Young Children in Bangladesh: A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet Global Health
Medicine
Immunogenicity and Safety of a 12-Valent Pneumococcal Conjugate Vaccine in Infants Aged 6 to 10 Weeks : A Randomized, Double Blind, Active-Controlled Trial
Clinical and Experimental Pediatrics
Safety and Immunogenicity of a Live-Attenuated Junin (Argentine Hemorrhagic Fever) Vaccine in Rhesus Macaques
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
A Second Dose of a Measles-Mumps-Rubella Vaccine Administered to Healthy Four-To-Six-Year-Old Children: A Phase III, Observer-Blind, Randomized, Safety and Immunogenicity Study Comparing GSK MMR and MMR II With and Without DTaP-IPV and Varicella Vaccines Co-Administration
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
